1-3 of 3
Authors: Peter Rossing
Sort by
Journal Article
Hypokalaemia in patients with type 2 diabetes and chronic kidney disease: the effect of finerenone—a FIDELITY analysis Open Access
Bertram Pitt and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 1, January 2025, Pages 10–19, https://doi.org/10.1093/ehjcvp/pvae074
Published: 08 October 2024
Journal Article
Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis Open Access
Gerasimos Filippatos and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 2, March 2023, Pages 183–191, https://doi.org/10.1093/ehjcvp/pvad001
Published: 13 January 2023
Journal Article
Finerenone efficacy in patients with chronic kidney disease, type 2 diabetes and atherosclerotic cardiovascular disease Open Access
Gerasimos Filippatos and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 1, January 2023, Pages 85–93, https://doi.org/10.1093/ehjcvp/pvac054
Published: 17 October 2022
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals